http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2666242-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7695b91bb0fc9195d18cac6b2d3a564b |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2017-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c846f20e30f81d454fac997050ccb74a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2670cb038b3a847f9fdeadc3ab8b82e0 |
| publicationDate | 2018-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2666242-C1 |
| titleOfInvention | Oral dosage form of 3,3'-diindolylmethane |
| abstract | FIELD: pharmaceutics. n SUBSTANCE: invention relates to pharmaceutical industry and relates to an oral dosage form of 3,3'-diindolyl methane for use in therapy of tumor processes in the organs of the reproductive system. Drug includes 3,3'-diindolyl methane, Polysorbate 80 and dimethylsulfoxide in the amounts indicated in the claims. Resulting solution is encapsulated using hard gelatin capsules. Dimethylsulfoxide accelerates the dissolution process 3,3'-diindolyl methane and provides more concentrated solutions of the preparation. Technical result achieved with the use of invention consists in obtaining a preparation that meets the requirements of the State Pharmacopeia of the XIII edition, having a shelf life of at least 2 years and providing a high pharmacotherapeutic effect of the active substance. n EFFECT: technological features of production of this form of the drug do not create difficulties in its mass production, and the consumer form provides convenience in receiving and storing. n 1 cl, 1 dwg, 1 tbl, 3 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021188012-A1 |
| priorityDate | 2017-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 40.